Professor Dr. Pier Vittorio Nardi, Neurosurgeon at the University La Sapienza in Rome, Italy Performs 2…
Continue ReadingTag: medovex-corporation
Medovex Corporation DenerveX System Reports on First Two Completed Cases in Germany
"DenerveX System has great potential in the treatment of Facet Joint Pain and could become the…
Continue ReadingMedovex Corporation DenerveX System First Cases to Commence in Germany
Dr. Martin Deeg to Use Recently CE Marked Device in Three Patients on July 26th in…
Continue ReadingUPDATE – Medovex Corporation Announces First Human Cases Using Its DenerveX Device and First Revenue Events
Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options…
Continue ReadingMedovex Announces First Human Cases Using Its DenerveX Device and First Revenue Events
Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options…
Continue ReadingMedovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement
ATLANTA, GA -- (Marketwired) -- 07/17/17 -- (NASDAQ: MDVX), a developer of medical technology products, today…
Continue ReadingMedovex Corporation Updates European Union Launch Progress
Initial Orders for Company--s CE Marked and Highly Disruptive DenerveX(TM) System Exceeding Internal Expectations
Continue ReadingMedovex Corporation Schedules First Human Case for DenerveX(TM) System
Recently CE Marked and Highly Disruptive Device with Faster Recovery Time than Current Surgical Treatment Options…
Continue ReadingMedovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System
Recently CE Marked and Highly Disruptive Device with Faster Recovery Time than Current Surgical Treatment Options…
Continue ReadingMedovex Corporation Releases Letter to Shareholders
ATLANTA, GA -- (Marketwired) -- 06/12/17 -- Medovex Corp. (NASDAQ: MDVX), a developer of medical technology…
Continue Reading